Active Ingredient: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Proprietary Name: OSMOPREP
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.398GM;1.102GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N021892
Product Number: 001
Approval Date: Mar 16, 2006
Applicant Holder Full Name: SALIX PHARMACEUTICALS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
